- Home
- MHH vs UNCY Comparison
MHH vs UNCY Comparison
Compare MHH & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- UNCY
- Stock Information
- Founded
- MHH 1986
- UNCY 2016
- Country
- MHH United States
- UNCY United States
- Employees
- MHH N/A
- UNCY N/A
- Industry
- MHH Professional Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- UNCY Health Care
- Exchange
- MHH Nasdaq
- UNCY Nasdaq
- Market Cap
- MHH 86.6M
- UNCY 74.2M
- IPO Year
- MHH N/A
- UNCY 2021
- Fundamental
- Price
- MHH $7.39
- UNCY $4.08
- Analyst Decision
- MHH
- UNCY Strong Buy
- Analyst Count
- MHH 0
- UNCY 5
- Target Price
- MHH N/A
- UNCY $55.20
- AVG Volume (30 Days)
- MHH 10.8K
- UNCY 447.8K
- Earning Date
- MHH 11-05-2025
- UNCY 11-12-2025
- Dividend Yield
- MHH N/A
- UNCY N/A
- EPS Growth
- MHH N/A
- UNCY N/A
- EPS
- MHH 0.07
- UNCY N/A
- Revenue
- MHH $200,000,000.00
- UNCY N/A
- Revenue This Year
- MHH N/A
- UNCY N/A
- Revenue Next Year
- MHH $3.78
- UNCY $4,481.14
- P/E Ratio
- MHH $102.00
- UNCY N/A
- Revenue Growth
- MHH 5.16
- UNCY N/A
- 52 Week Low
- MHH $6.20
- UNCY $3.40
- 52 Week High
- MHH $16.00
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- MHH 50.93
- UNCY 42.66
- Support Level
- MHH N/A
- UNCY $3.80
- Resistance Level
- MHH $7.90
- UNCY $4.21
- Average True Range (ATR)
- MHH 0.32
- UNCY 0.20
- MACD
- MHH -0.32
- UNCY -0.01
- Stochastic Oscillator
- MHH 90.12
- UNCY 41.27
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.